Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
Titel:
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
Auteur:
Barbanti, Piero Egeo, Gabriella Aurilia, Cinzia Torelli, Paola Finocchi, Cinzia d’Onofrio, Florindo d’Onofrio, Luigi Rao, Renata Messina, Stefano Di Clemente, Laura Ranieri, Angelo Autunno, Massimo Sette, Giuliano Colombo, Bruno Carnevale, Antonio Aguggia, Marco Tasillo, Miriam Zoroddu, Francesco Frediani, Fabio Filippi, Massimo Tomino, Carlo Proietti, Stefania Bonassi, Stefano ,